Literature DB >> 24389360

Identification of novel alternative splicing events in the huntingtin gene and assessment of the functional consequences using structural protein homology modelling.

Alis C Hughes1, Matthew Mort2, Lyn Elliston3, Rhian M Thomas4, Simon P Brooks5, Stephen B Dunnett6, Lesley Jones7.   

Abstract

Huntington's disease (HD) is an inherited progressive neurodegenerative disorder caused by a pathological CAG trinucleotide repeat expansion in the large multi-exon gene, huntingtin (HTT). Although multiple pathogenic mechanisms have been proposed for HD, there is increasing interest in the RNA processing of the HTT gene. In mammals, most multi-exon genes are alternatively spliced; however, few alternative transcripts have been described for HTT. Given the numerous protein bands detected in mouse and human brain tissue by Western blotting using anti-huntingtin antibodies, we examined whether alternative splicing of HTT may account for some of these fragments. Using RT-PCR in mouse brain, we detected two novel splice variants of Htt that lacked the 111-bp exon 29 (Htt∆ex29) or retained a 57-bp portion of intron 28 (Htt(+57)in28) via use of a cryptic splice site. The alternative transcripts were present in wild-type and homozygous Hdh(Q150/Q150) mouse brain at all ages and in all brain regions and peripheral tissues studied. Differential splicing of Htt∆ex29 was found in the cerebellum of Hdh(Q150/Q150) mice with a significant reduction in transcript levels in mutant animals. In human brain, we detected similar splice variants lacking exons 28 and 29. The ability of alternatively spliced transcripts to encode different protein isoforms with individual functions in the cell, combined with the known role of splicing in disease, renders these novel transcripts of interest in the context of HD pathogenesis.
Copyright © 2013. Published by Elsevier Ltd.

Entities:  

Keywords:  Huntington's disease; RNA processing; alternative transcripts; pathogenesis; protein modelling

Mesh:

Substances:

Year:  2014        PMID: 24389360     DOI: 10.1016/j.jmb.2013.12.028

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  6 in total

1.  Discovery of novel isoforms of huntingtin reveals a new hominid-specific exon.

Authors:  Albert Ruzo; Ismail Ismailoglu; Melissa Popowski; Tomomi Haremaki; Gist F Croft; Alessia Deglincerti; Ali H Brivanlou
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

2.  The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington's disease patients.

Authors:  Andreas Neueder; Christian Landles; Rhia Ghosh; David Howland; Richard H Myers; Richard L M Faull; Sarah J Tabrizi; Gillian P Bates
Journal:  Sci Rep       Date:  2017-05-02       Impact factor: 4.379

Review 3.  Huntington Disease as a Neurodevelopmental Disorder and Early Signs of the Disease in Stem Cells.

Authors:  Kalina Wiatr; Wojciech J Szlachcic; Marta Trzeciak; Marek Figlerowicz; Maciej Figiel
Journal:  Mol Neurobiol       Date:  2017-05-11       Impact factor: 5.590

4.  Regulatory mechanisms of incomplete huntingtin mRNA splicing.

Authors:  Andreas Neueder; Anaelle A Dumas; Agnesska C Benjamin; Gillian P Bates
Journal:  Nat Commun       Date:  2018-09-27       Impact factor: 14.919

5.  Evidence of Extensive Alternative Splicing in Post Mortem Human Brain HTT Transcription by mRNA Sequencing.

Authors:  Adam T Labadorf; Richard H Myers
Journal:  PLoS One       Date:  2015-10-23       Impact factor: 3.240

Review 6.  A Fresh Look at Huntingtin mRNA Processing in Huntington's Disease.

Authors:  Lindsay Romo; Emily S Mohn; Neil Aronin
Journal:  J Huntingtons Dis       Date:  2018
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.